MS Research Australia triumphs at national Charity Awards

28th August 2018

MS Research Australia has been recognised for ‘Outstanding Achievement’ in the Australian Charity Awards 2018.

Dancing for MS: Portugal’s new awareness campaign

27th August 2018

The Portuguese MS Society (SPEM) is calling on people nationwide to raise awareness of MS through dance…

Signs of MS may start five years before diagnosis

26th August 2018

Canadian research shows people with MS are more likely than the general population to visit a doctor…

Study suggests improvement in MS employment outcomes

24th August 2018

New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown…

Primary progressive MS risk may be linked to genes that cause other brain diseases 

23rd August 2018

Genetic screening of people with primary progressive MS has shown that four rare genetic changes, which are…

‘Rings of fire’: blocking the death of brain cells in MS

21st August 2018

A new study that suggests inflammation may lead to the death of brain cells in MS may…

New Zealand launches country’s first MS registry

31st July 2018

The New Zealand Multiple Sclerosis Research Trust invited Professor Helmut Butzkueven, Managing Director of MSBase, to launch…

Join our team – Capacity Building Support Officer (Arab region)

31st July 2018

Temporary part-time role to support our Arab region capacity building work

Highlights from the Cykelnerven cycling challenge

31st July 2018

Daniel Magson, Fundraising Campaigns Manager at MSIF, shares the highlights from Cykelnerven, a new and unique charity…

ARSEP awards 1.6m EUR to MS research proposals

30th July 2018

The Scientific Committee of the French MS Research Support Foundation (ARSEP) has selected recipients for its annual…

Over 20,000 people sign UK MS Society’s petition to improve disability benefit for people with MS

26th July 2018

The UK MS Society’s campaign calls on the government to change criteria of Personal Independence Payments (PIP),…

Natalizumab treatment may preserve upper limb function in secondary progressive MS

25th July 2018

Results from a trial of natalizumab in secondary progressive MS suggest anti-inflammatory treatments could slow disability accumulation,…